Web Analytics

3 Latest Announced Rounds

  • $2,500,000
    Unknown

    1 Investors

    Services for Renewable Energy
    Nov 22nd, 2024
  • $1,447,585
    Seed
    Design Services
    Nov 22nd, 2024
  • $45,000,000
    Series C

    1 Investors

    Renewable Energy Semiconductor Manufacturing
    Nov 22nd, 2024
$2,199.23M Raised in 91 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Mable | Neurolytic Healthcare

start up
United States - San Francisco, California
  • 27/07/2022
  • Seed
  • $3,200,000

Migraines are heritable. Uncover the link between your genetics and migraines to help prevent your migraine in advance and get medication delivered directly to your door.


Related People

Roman RothaermelCo Founder

Roman Rothaermel United Kingdom - London, England

Before founding Mable, I was a researcher at the University of Oxford working at the intersection between neuroscience, data science and pharmacology. Today at Mable, we're using data-driven approaches to fight neurological conditions starting with migraines - a problem that affects 12% of the population and is in urgent need of innovation in care quality and delivery mechanisms.